Eurocor GmbH has entered into a licensing agreement with Biosensors International Group Ltd to manufacture catheters for treating heart diseases. Eurocor is a group firm of medical technology leader Opto Circuits India Ltd.
As part of the agreement, Eurocor will manufacture three medical devices using Biosensors' drug eluting balloon (DEB) technology for treating coronary and artery diseases, while the latter will market them worldwide.
Diet, Lifestyle and Heart Disease
The correlation between diet, lifestyle and heart disease. The importance of balanced diet life style and exercise for controlling heart disease.
Advertisement
"The three devices are drug-eluting balloon dilatation catheters designed for percutaneous transluminal angioplasty. The first one -- BioStream has been developed for coronary arteries, BioPath for treating patients with peripheral arterial disease and BioPath 035 for peripheral intervention above knee," the company said in a statement here.
The devices will feature Eurocor's proprietary coating, delivering paclitaxel, an anti-restenotic drug, used in DEB applications.
"The innovative devices will complement our cardiac stents and facilitate our entry into the peripheral vascular disease market," Biosensors cardiovascular division president Jeffrey B. Jump said in the statement.
![Heart Attack]( "Heart Attack")
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.
The devices will be launched in European markets and in select regions across Asia, Africa and West Asia after securing the European Conformance Marking (CE) in next six weeks.
"The agreement validates our DEB products and enables us to enter the rapidly-growing sector of the interventional devices market," Eurocor chief operating officer Antonino Laudani said.
As a vertically integrated medical technology group, the Bangalore-based Opto Circuits specialises in primary, acute and critical care devices for global markets.
Specialising in research, development and manufacture of cardiovascular and endovascular products, Eurocor provides interventional physicians with coronary stents and special cardiovascular and endovascular devices.
Source: IANS
"The innovative devices will complement our cardiac stents and facilitate our entry into the peripheral vascular disease market," Biosensors cardiovascular division president Jeffrey B. Jump said in the statement.
Heart Attack
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.
Advertisement
The devices will be launched in European markets and in select regions across Asia, Africa and West Asia after securing the European Conformance Marking (CE) in next six weeks.
"The agreement validates our DEB products and enables us to enter the rapidly-growing sector of the interventional devices market," Eurocor chief operating officer Antonino Laudani said.
As a vertically integrated medical technology group, the Bangalore-based Opto Circuits specialises in primary, acute and critical care devices for global markets.
Specialising in research, development and manufacture of cardiovascular and endovascular products, Eurocor provides interventional physicians with coronary stents and special cardiovascular and endovascular devices.
Source: IANS
Lifestyle Paths to Heart Disease
Heart disease can be of many types depending upon whether they involve the heart muscles or artery walls or heart beats. Bad lifestyle choices contribute to heart disease.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Corporate News
The first World Health Organisation (WHO)/ International Labour Organisation (ILO) joint global monitoring report shows that more action is needed to ensure healthier, safer, more resilient, and more social workplaces.
Successful career transitions could be possible when people leverage their existing skills in the new occupation. A new Artificial Intelligence tool helps employees figure out the right job according to their current skill set.
AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs
Insurance companies in the US are working towards adding food to their coverage menu to improve the people's health under their coverage and cut hospital costs.
Pharmaceutical companies need to make strategic decisions that will provide financial benefit while showing strong commitment to global health and their patients during the pandemic.